EB-1A and EB-2 NIW Visas for Biotech Scientists

Biotechnology and life sciences represent one of the most strategic sectors of the United States economy, generating trillions of dollars per year and employing millions of professionals in research, development, and production. For scientists and researchers working in this field, the country offers immigration pathways specifically designed to attract exceptional talent: the EB-1A (Extraordinary Ability) and EB-2 NIW (National Interest Waiver) visas.

The distinguishing feature of these programs is that both waive the job offer and labor certification requirements, allowing the professional to self-petition directly to USCIS. The key to success lies in translating scientific achievements into evidence that meets the legal criteria established by 8 CFR 204.5(h)(3) for EB-1A and the Dhanasar test for EB-2 NIW.

This guide details how professionals in biotechnology, pharmacology, genetics, bioinformatics, and related fields can structure their immigration case based on documentable scientific contributions.

Scientific Evidence for Immigration

USCIS evaluates scientists’ petitions based on documentary evidence of impact, originality, and recognition. Having an extensive CV is not enough: it is necessary to demonstrate that your work has made a measurable difference in the field. For biotech and life sciences professionals, four categories of evidence stand out.

High-Impact Publications

Articles published in journals with a rigorous peer review system constitute the most direct proof of original contribution to the field. Journals such as Nature, Science, Cell, The Lancet, PNAS, and Journal of Biological Chemistry are examples of outlets with high impact factors. First or corresponding authorship carries special weight, as it indicates intellectual leadership in the research.

For EB-1A, publications meet the “authorship of scholarly articles” criterion set forth in 8 CFR 204.5(h)(3)(vi). The journal’s impact factor and the number of citations received significantly strengthen the argument that the work is recognized by the international scientific community.

Biomedical Patents

Patents registered with the USPTO (United States Patent and Trademark Office) or with international offices via PCT demonstrate that your research has produced innovation with practical application. In biotechnology, patents for new pharmaceutical compounds, monoclonal antibodies, molecular diagnostic methods, medical devices, or biotechnological processes are particularly strong evidence.

A granted patent proves that the invention was considered novel, useful, and non-obvious. These three patentability requirements align directly with what USCIS seeks in “evidence of original contributions of major significance,” as per 8 CFR 204.5(h)(3)(v).

Clinical Research

Participation in clinical trials, especially in phases II and III, demonstrates direct involvement in research with public health impact. For USCIS, what matters is documenting your specific role: protocol design, statistical data analysis, patient safety supervision, or publication of results.

Researchers who contributed to the development of drugs approved by the FDA (Food and Drug Administration) or vaccines that received authorization have exceptionally strong evidence of contribution to the American national interest. This type of proof is valued in both EB-1A and EB-2 NIW.

Citations and Peer Review

A robust citation profile, measurable via Google Scholar, Scopus, or Web of Science, indicates that other scientists consider your work relevant enough to support their own research. For EB-1A, high citations demonstrate recognition by the field and lasting influence.

Invitations to serve as a peer reviewer for prestigious journals or international conferences constitute additional evidence of authority. This role as “judge of the work of others” directly meets the criterion of 8 CFR 204.5(h)(3)(iv) and reinforces the petitioner’s position as a reference in their specialty.

EB-1A for Scientists

The EB-1A visa requires the petitioner to demonstrate “extraordinary ability” in their field, proven by a major international award (such as the Nobel Prize) or, alternatively, by meeting at least 3 of the 10 regulatory criteria listed in 8 CFR 204.5(h)(3). For biotech scientists, the most commonly applicable criteria are:

• Academic publications in peer-reviewed journals
• Original contributions of major significance to the field
• Judging the work of others as a peer reviewer
• Membership in organizations that require outstanding achievements
• High remuneration compared to peers in the same field

After the two-step Kazarian analysis, USCIS first checks if the petitioner meets the individual criteria and then evaluates the totality of the evidence to determine if the professional truly stands at the top of their field. In April 2026, the I-140 petition fee for EB-1A is $715, with premium processing available for $2,965 and a 15-business-day timeframe. Regular processing takes 6 to 19 months.

EB-2 NIW and the Dhanasar Test

The EB-2 NIW allows professionals with an advanced degree (master’s or higher, or bachelor’s with five years of progressive experience) to petition without a job offer, provided they demonstrate that their work serves the national interest of the U.S. The evaluation follows the three-prong test established in Matter of Dhanasar (2016):

1. Substantial merit and national importance: the proposed endeavor must have significant value in areas such as science, technology, public health, or the economy
2. Position to advance the endeavor: the petitioner must demonstrate qualification, track record, and a concrete plan to carry out the proposed work
3. Benefit to the national interest: it must be more advantageous for the U.S. to waive the job offer and labor certification than to require them

For biotechnology scientists, the third point is often the strongest. Research in oncology, infectious diseases, gene therapies, food safety, and agricultural biotechnology connects directly to national health and security priorities. In 2026, USCIS continues to prioritize professionals in STEM fields, especially those working with Critical and Emerging Technologies defined by the White House.

Regular I-140 processing for EB-2 NIW takes approximately 22.5 months in mid-2026. Premium processing is available for $2,965, with a 45-calendar-day timeframe.

Costs and Timelines in 2026

These amounts reflect the USCIS fee schedule updated in March 2026 and are subject to change. The current official table can be found at uscis.gov/g-1055.

Frequently Asked Questions

Industry vs. Academia

USCIS values significant contributions from both environments. A scientist in the pharmaceutical industry who played a critical role in the development of an FDA-approved drug has evidence of impact as strong as an academic researcher with high-impact publications. What matters for adjudication is the relevance and originality of the contribution, not the type of institution where the work was performed.

Theoretical Research

For basic or theoretical science research, impact is measured by the advancement of knowledge in the field. The main evidence includes publications in prestigious journals, volume of citations received, and recommendation letters from recognized academics attesting that the research served as a foundation for subsequent work. Demonstrating that theoretical research paved the way for future practical applications significantly strengthens the case before USCIS.

Regulatory Affairs

Professionals with experience navigating FDA approval processes possess a rare skill set highly valued by the market and the U.S. government. Expertise in regulatory affairs, which involves ensuring that new drugs, medical devices, and therapies reach the market safely and efficiently, is considered of national importance. These professionals often qualify for both EB-1A and EB-2 NIW, depending on their level of seniority and the robustness of the available documentary evidence.

About the author

Victoria Harper

Editor-in-Chief

Meet the author

As a journalist and lead editor at Visto n’ Visa, Victoria helps ensure that immigration topics are covered in a clear, trustworthy, and easy-to-understand way. Her focus is on delivering useful, human, and relevant content for people exploring new paths abroad.